Nasr SH, D’Agati VD. IgA-dominant postinfectious

glomerulonephritis: A new twist on an old disease.

Nephron Clin Pract. 2011; 119(1):c18-25; discussion

c26. [PMID]

Glassock RJ, Alvarado A, Prosek J, Hebert C, Parikh S, Satoskar A, et al. Staphylococcus-related glomerulonephritis

and poststreptococcal glomerulonephritis: Why defining

"post" is important in understanding and treating infectionrelated glomerulonephritis. Am J Kidney Dis. 2015; 65(6):826-

[DOI:10.1053/j.ajkd.2015.01.023] [PMID]

Nasr SH, Fidler ME, Valeri [4] Nasr SH, Markowitz GS, Whelan JD, Albanese JJ, Rosen

RM, Fein DA, et al. IgA-dominant acute poststaphylococcal glomerulonephritis complicating diabetic nephropathy.

Hum Pathol. 2003; 34(12):1235-41. [DOI:10.1016/S0046-

(03)00424-6] [PMID]

Handa T, Kakita H, Tateishi Y, Endo T, Suzuki H, Katayama T, et al. The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: A

single-center study. Clin Exp Nephrol. 2018; 22(5):1116-27.

[DOI:10.1007/s10157-018-1564-4] [PMID]

Hunt EAK, Somers MJG. Infection-related glomerulonephritis. Pediatr Clin North Am. 2019; 66(1):59-72. [DOI:10.1016/j.

pcl.2018.08.005] [PMID]

Satoskar AA, Nadasdy G, Plaza JA, Sedmak D, Shidham

G, Hebert L, et al. Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc

Nephrol. 2006; 1(6):1179-86. [DOI:10.2215/CJN.01030306]

[PMID]

Worawichawong S, Girard L, TrpkovK,Gough JC, Gregson

DB, Benediktsson H. Immunoglobulin a-dominant postinfectious glomerulonephritis: Frequent occurrence in nondiabetic

patients with Staphylococcus au-reus infection. Hum Pathol.

; 42(2):279-84. [DOI:10.1016/j.humpath.2010.07.009]

[PMID]

Khalighi MA, Al-Rabadi L, Chalasani M, Smith M, Kakani

S, Revelo MP, et al. Staphylococcal Infection-related glomerulonephritis with cryoglobulinemic features. Kidney Int Rep.

; 3(5):1128-34. [DOI:10.1016/j.ekir.2018.05.010] [PMID]

Nasr SH, Markowitz GS, Stokes MB, Said SM, Valeri

AM, D'Agati VD. Acute postinfectious glomerulonephritis

in the modern era: Experience with 86 adults and review

of the literature. Medicine. 2008; 87(1):21-32. [DOI:10.1097/

md.0b013e318161b0fc] [PMID]

Kambham N. Postinfectious glomerulonephritis. Adv Anat Pathol. 2012; 19(5):338-47. [DOI:10.1097/

PAP.0b013e31826663d9] [PMID]

Haas M, Racusen LC, Bagnasco SM. IgA-dominant postinfectious glomerulonephritis: A report of 13 cases with common ultrastructural features. Hum Pathol. 2008; 39(9):1309-

[DOI:10.1016/j.humpath.2008.02.015] [PMID]

Khalighi MA, Wang S, Henriksen KJ, Bock M, Keswani M,

Meehan SM, et al. Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy. Clin Kidney J. 2016; 9(3):397-402. [DOI:10.1093/ckj/sfw032] [PMID]

Bu R, Li Q, Duan ZY, Wu J, Chen P, Chen XM, et al. Clinicopathologic features of IgA-dominant infection-associated glomerulonephritis: A pooled analysis of 78 cases. Am J Nephrol.

; 41(2):98-106. [DOI:10.1159/000377684] [PMID]

Arivazhagan S, Lamech TM, Myvizhiselvi M, Arumugam

V, Alavudeen SS, Dakshinamoorthy S, et al. Efficacy of corticosteroids in infection-related glomerulonephritis-a randomized controlled trial. Kidney Int Rep. 2022; 7(10):2160-5.

[DOI:10.1016/j.ekir.2022.07.163] [PMID] [PMCID]

Sethi S, Fervenza FC, Zhang Y, Zand L, Meyer NC, Borsa

N, et al. Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int. 2013; 83(2):293-9. [DOI:10.1038/ki.2012.384]

[PMID] [PMCID]

Trivedi M, Pasari A, Chowdhury AR, Kurien AA, Pandey R. The epidemiology, clinical features, and outcome of

infection-related glomerulonephritis from East India: A single center experience. Indian J Nephrol. 2017; 27(4):307-12.

[DOI:10.4103/ijn.IJN_280_16] [PMID] [PMCID]AM, Cornell LD, Sethi S,

Zoller A, et al. Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol. 2011; 22(1):187-95. [DOI:10.1681/

ASN.2010060611] [PMID]